Why the Market Dipped But Oscar Health, Inc. (OSCR) Gained Today

Oscar Health (OSCR) recently outperformed the broader market, gaining 1.42% while the S&P 500 declined, and posted an 8.92% monthly increase. Ahead of its November 6, 2025 earnings report, analysts anticipate a significant 150% year-over-year decline in EPS to -$0.55, contrasting with a projected 27.51% revenue increase to $3.09 billion. The company holds a Zacks Rank of #3 (Hold), with consensus EPS estimates remaining unchanged over the past month, indicating a mixed outlook of strong top-line growth against ongoing profitability challenges.

Analysis

Oscar Health, Inc. (OSCR) recently demonstrated notable market outperformance, gaining 1.42% in a session where the S&P 500 declined by 0.16%. Over the past month, OSCR shares surged 8.92%, significantly surpassing the Finance sector's 1.81% loss and the S&P 500's 1.14% gain. This strong short-term price momentum suggests specific investor interest despite broader market weakness.

The company's upcoming earnings report on November 6, 2025, presents a mixed financial picture. Analysts project a substantial 150% year-over-year decline in EPS to -$0.55, contrasting sharply with an anticipated robust 27.51% increase in revenue to $3.09 billion. Full-year estimates further reinforce this trend, forecasting a 1520% EPS decline to -$1.42 against a strong 31.44% revenue growth to $12.06 billion.

Despite the strong top-line growth projections, the persistent negative EPS outlook contributes to Oscar Health's current Zacks Rank of #3 (Hold), with no change in consensus EPS estimates over the past month. The company operates within the Insurance - Multi line industry, which holds a favorable Zacks Industry Rank of 76, placing it in the top 31% of all industries. This indicates a supportive industry environment, but OSCR's path to profitability remains a critical concern.

Key Decisions for Investors

• Monitor the upcoming November 6, 2025 earnings report closely for actual revenue growth and any signs of improved profitability metrics, as strong revenue is currently offset by significant EPS declines.
• Evaluate the sustainability of OSCR's revenue growth against its persistent negative earnings per share, focusing on management's strategy to achieve positive earnings.
• Assess analyst revisions post-earnings, as unchanged EPS estimates over the past month suggest a stable but negative profitability outlook, despite recent stock outperformance.